[1] D S JOHNSON. alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.[J]. Molecular Pharmacology, 1995, 48 2: 194-199.
[2] DONG MEI. The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.[J]. Biomaterials, 2015, 42: 52-65. DOI:
10.1016/j.biomaterials.2014.11.044[3] J M MCINTOSH. A nicotinic acetylcholine receptor ligand of unique specificity, alpha-conotoxin ImI.[J]. The Journal of Biological Chemistry, 1994, 269 24: 16733-16739.